These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

318 related items for PubMed ID: 24001518

  • 1. Malignant ovarian germ cell tumors: presentation, survival and second cancer in a population based Norwegian cohort (1953-2009).
    Solheim O, Kærn J, Tropé CG, Rokkones E, Dahl AA, Nesland JM, Fosså SD.
    Gynecol Oncol; 2013 Nov; 131(2):330-5. PubMed ID: 24001518
    [Abstract] [Full Text] [Related]

  • 2. [Clinical analysis of 15 cases of malignant ovarian germ cell tumors with lung metastasis].
    Liu Y, Ren T, Feng FZ, Wan XR, Shen K, Xiang Y.
    Zhonghua Fu Chan Ke Za Zhi; 2012 Jan; 47(1):40-4. PubMed ID: 22455692
    [Abstract] [Full Text] [Related]

  • 3. Malignant ovarian germ cell tumors: clinico-pathological presentation and survival outcomes.
    Tangjitgamol S, Hanprasertpong J, Manusirivithaya S, Wootipoom V, Thavaramara T, Buhachat R.
    Acta Obstet Gynecol Scand; 2010 Jan; 89(2):182-9. PubMed ID: 19961281
    [Abstract] [Full Text] [Related]

  • 4. Germ cell tumors of the ovary.
    Pectasides D, Pectasides E, Kassanos D.
    Cancer Treat Rev; 2008 Aug; 34(5):427-41. PubMed ID: 18378402
    [Abstract] [Full Text] [Related]

  • 5. [Treatment of malignant ovarian germ cell tumors with relapse or failed in primary therapy].
    Yang JX, Wang HB, Shen K, Huang HF, Pan LY, Wu M.
    Zhonghua Fu Chan Ke Za Zhi; 2009 Apr; 44(4):273-6. PubMed ID: 19570465
    [Abstract] [Full Text] [Related]

  • 6. Outcomes of pediatric and adolescent girls with malignant ovarian germ cell tumors.
    Park JY, Kim DY, Suh DS, Kim JH, Kim YM, Kim YT, Nam JH.
    Gynecol Oncol; 2015 Jun; 137(3):418-22. PubMed ID: 25842162
    [Abstract] [Full Text] [Related]

  • 7. [BEP/VIP in children and adolescents with malignant non-testicular germ cell tumors. A comparison of the results of treatment of therapy studies MAKEI 83/86 and 89P/89].
    Göbel U, Calaminus G, Teske C, Bamberg M, Bökkerink JP, Haas RJ, Holschneider AM, Janka-Schaub G, Jürgens H, Mittler U.
    Klin Padiatr; 1993 Jun; 205(4):231-40. PubMed ID: 7690864
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Impact of surgery, chemotherapy and irradiation on long term outcome of intracranial malignant non-germinomatous germ cell tumors: results of the German Cooperative Trial MAKEI 89.
    Calaminus G, Bamberg M, Jürgens H, Kortmann RD, Sörensen N, Wiestler OD, Göbel U.
    Klin Padiatr; 2004 Jun; 216(3):141-9. PubMed ID: 15175958
    [Abstract] [Full Text] [Related]

  • 11. Outcome of recurrent and persistent disease of malignant ovarian germ cell tumor: a retrospective analysis at King Chulalongkorn Memorial Hospital.
    Lertkhachonsuk R, Manchana T, Termrungruanglert W, Vasuratna A, Sittisomwong T, Worasethsin P, Sirisabya N, Khemapech N, Tresukosol D.
    J Med Assoc Thai; 2006 Feb; 89(2):138-44. PubMed ID: 16578998
    [Abstract] [Full Text] [Related]

  • 12. Late relapses (>2 years) in patients with stage I testicular germ cell tumors: predictive factors and survival.
    Fedyanin M, Tryakin A, Kanagavel D, Bulanov A, Burova A, Figurin K, Fainshtein I, Sergeev U, Zakharova T, Garin A, Tjulandin S.
    Urol Oncol; 2013 May; 31(4):499-504. PubMed ID: 21803619
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Nondysgerminomatous ovarian tumors: clinical characteristics, treatment, and outcome. A case-controlled study.
    Ghaemmaghami F, Hasanzadeh M, Karimi Zarchi M, Fallahi A.
    Int J Surg; 2008 Oct; 6(5):382-6. PubMed ID: 18715834
    [Abstract] [Full Text] [Related]

  • 16. Malignant ovarian germ cell tumors in pediatric patients: The AIEOP (Associazione Italiana Ematologia Oncologia Pediatrica) study.
    Terenziani M, Bisogno G, Boldrini R, Cecchetto G, Conte M, Boschetti L, De Pasquale MD, Biasoni D, Inserra A, Siracusa F, Basso ME, De Leonardis F, Di Pinto D, Barretta F, Spreafico F, D'Angelo P.
    Pediatr Blood Cancer; 2017 Nov; 64(11):. PubMed ID: 28449306
    [Abstract] [Full Text] [Related]

  • 17. Is carboplatin-based chemotherapy as effective as cisplatin-based chemotherapy in the treatment of advanced-stage dysgerminoma in children, adolescents and young adults?
    Shah R, Xia C, Krailo M, Amatruda JF, Arul SG, Billmire DF, Brady WE, Covens A, Gershenson DM, Hale JP, Hurteau J, Murray MJ, Nicholson JC, Olson TA, Pashankar F, Rodriguez-Galindo C, Shaikh F, Stark D, Frazier AL, Stoneham S.
    Gynecol Oncol; 2018 Aug; 150(2):253-260. PubMed ID: 29884437
    [Abstract] [Full Text] [Related]

  • 18. Prognostic factors and role of salvage surgery in chemorefractory ovarian germ cell malignancies: a study in Chinese patients.
    Li J, Yang W, Wu X.
    Gynecol Oncol; 2007 Jun; 105(3):769-75. PubMed ID: 17459461
    [Abstract] [Full Text] [Related]

  • 19. Malignant ovarian germ cell tumors: a single-institution experience.
    Cicin I, Eralp Y, Saip P, Ayan I, Kebudi R, Iyibozkurt C, Tuzlali S, Gorgun O, Topuz E.
    Am J Clin Oncol; 2009 Apr; 32(2):191-6. PubMed ID: 19307952
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.